Related Experiment Video
Updated: Jun 27, 2026

Robot-Assisted Transcanal Endoscopic Ear Surgery for Congenital Cholesteatoma
Published on: December 15, 2023
Complicated otitis media and its implications
1Pediatric Infectious Disease Unit, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel. eugenel@bgu.ac.il
Abstract:
Complicated otitis media (OM) is a common paediatric problem and includes two major entities: persistent acute OM (AOM) and recurrent AOM (R-AOM). Double-tympanocentesis studies comparing the microbiology of initial and recurrent episodes of AOM have demonstrated that most recurrent episodes occurring within 1 month after antibiotic therapy are new infections, not true bacteriological relapses. These findings have highlighted the importance of bacteriological eradication in the prevention of subsequent R-AOM episodes. The seven-valent pneumococcal conjugate vaccine (PCV7) targets Streptococcus pneumoniae, one of the main AOM pathogens, and data on the impact of PCV7 on complications of AOM, such as mastoiditis, are presented.
Insights
Recurrent otitis media (OM) is often caused by new infections, not relapses, emphasizing the need for bacterial eradication. The pneumococcal conjugate vaccine (PCV7) may help prevent OM complications like mastoiditis.
Area of Science:
- Pediatric infectious diseases
- Otolaryngology
- Vaccinology
Background:
- Complicated otitis media (OM), including persistent and recurrent acute otitis media (AOM), is a significant pediatric health issue.
- Microbiological studies indicate that most recurrent AOM episodes within a month of antibiotic treatment are new infections, not relapses.
Purpose of the Study:
- To highlight the importance of bacteriological eradication for preventing recurrent acute otitis media (R-AOM).
- To present data on the impact of the seven-valent pneumococcal conjugate vaccine (PCV7) on AOM complications, specifically mastoiditis.
Main Methods:
- Review of double-tympanocentesis studies comparing microbiology of initial and recurrent AOM episodes.
- Analysis of data concerning the effects of PCV7 on AOM complications.
Main Results:
- Most recurrent AOM episodes within one month post-antibiotic therapy are identified as new infections.
- The seven-valent pneumococcal conjugate vaccine (PCV7) targets key AOM pathogens like Streptococcus pneumoniae.
Conclusions:
- Bacteriological eradication is crucial for preventing subsequent R-AOM episodes.
- PCV7 shows potential in reducing AOM complications, including mastoiditis.
Related Concept Videos
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Pneumonia III: Complications and Assessment
Bacterial Meningitis I: Introduction
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Microbiota of the Respiratory Tract
Tonsillitis II: Management
